How Claritin broke the televisual levee
(ALEX HOGAN/STAT)
You’ve probably heard that, out of the roughly 200 countries in the entire world, the U.S. is one of just two that allows drug companies to advertise on TV. And you might have wondered: Why?
Welcome to "The Facts, STAT!", a new, not-infrequent STAT video series in which our reporters briefly explain the need-to-know basics of issues in the world of health care and biotech. You can expect graphics, charts, and a fair amount of information over the course of about a minute.
This time, we’re looking at how pitching pills on primetime went from a regulatory red line to a staple of modern broadcasting. It involves FDA vagaries, corporate cleverness, and countless invitations to “ask your doctor about Claritin.”
Watch the video.
Welcome to "The Facts, STAT!", a new, not-infrequent STAT video series in which our reporters briefly explain the need-to-know basics of issues in the world of health care and biotech. You can expect graphics, charts, and a fair amount of information over the course of about a minute.
This time, we’re looking at how pitching pills on primetime went from a regulatory red line to a staple of modern broadcasting. It involves FDA vagaries, corporate cleverness, and countless invitations to “ask your doctor about Claritin.”
Watch the video.
.png)
No hay comentarios:
Publicar un comentario